MLchartDataset catalogue

dendritic cell-gp100-MART-1 antigen vaccine

Term · Oncology and biomedicine · MLC-T-ONC-012966

An autologous dendritic cell vaccine with antineoplastic property. Dendritic cells harvested from cancer patients are pulsed with human gp100 melanoma antigen and MART-1 antigen (a melanoma antigen recognized by T-cells); both antigens are up-regulated in melanomas. Vaccination with this vaccine may elicit the host immune response against MART-1 or gp100 expressing cells.

Table 1. Record
IdentifierMLC-T-ONC-012966
FieldOncology and biomedicine
AbbreviationDC-gp100-MART-1
Synonymsgp100/Mart-1-transduced dendritic cell vaccine
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-012966",
  "term": "dendritic cell-gp100-MART-1 antigen vaccine",
  "field": "Oncology and biomedicine",
  "definition": "An autologous dendritic cell vaccine with antineoplastic property. Dendritic cells harvested from cancer patients are pulsed with human gp100 melanoma antigen and MART-1 antigen (a melanoma antigen recognized by T-cells); both antigens are up-regulated in melanomas. Vaccination with this vaccine may elicit the host immune response against MART-1 or gp100 expressing cells.",
  "abbreviation": "DC-gp100-MART-1",
  "synonyms": [
    "gp100/Mart-1-transduced dendritic cell vaccine"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/dendritic-cell-gp100-mart-1-antigen-vaccine/"
}

Record 5,810 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.